<VariationArchive RecordType="classified" VariationID="625943" VariationName="NM_000138.5(FBN1):c.2305_2315del (p.Cys769fs)" VariationType="Deletion" Accession="VCV000625943" Version="2" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-12-17" DateCreated="2019-04-26" MostRecentSubmission="2023-05-20">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="614400" VariationID="625943">
      <GeneList>
        <Gene Symbol="FBN1" FullName="fibrillin 1" GeneID="2200" HGNC_ID="HGNC:3603" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>15q21.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="15" Accession="NC_000015.10" start="48408313" stop="48645709" display_start="48408313" display_stop="48645709" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="15" Accession="NC_000015.9" start="48700502" stop="48937984" display_start="48700502" display_stop="48937984" Strand="-" />
          </Location>
          <OMIM>134797</OMIM>
          <Haploinsufficiency last_evaluated="2019-12-04" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=FBN1">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2019-12-04" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=FBN1">No evidence available</Triplosensitivity>
          <Property>gene_acmg_incidental_2013</Property>
          <Property>gene_acmg_incidental_2016</Property>
          <Property>gene_acmg_incidental_2021</Property>
          <Property>gene_acmg_incidental_2022</Property>
        </Gene>
      </GeneList>
      <Name>NM_000138.5(FBN1):c.2305_2315del (p.Cys769fs)</Name>
      <CanonicalSPDI>NC_000015.10:48496203:TTCAGTACACATTCA:TTCA</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>15q21.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="15" Accession="NC_000015.10" start="48496204" stop="48496214" display_start="48496204" display_stop="48496214" variantLength="11" positionVCF="48496203" referenceAlleleVCF="GTTCAGTACACA" alternateAlleleVCF="G" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="15" Accession="NC_000015.9" start="48788401" stop="48788411" display_start="48788401" display_stop="48788411" variantLength="11" positionVCF="48788400" referenceAlleleVCF="GTTCAGTACACA" alternateAlleleVCF="G" />
      </Location>
      <ProteinChange>C769fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000015.10" sequenceAccession="NC_000015" sequenceVersion="10" change="g.48496208_48496218del" Assembly="GRCh38">
            <Expression>NC_000015.10:g.48496208_48496218del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000015.9" sequenceAccession="NC_000015" sequenceVersion="9" change="g.48788405_48788415del" Assembly="GRCh37">
            <Expression>NC_000015.9:g.48788405_48788415del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008805.2" sequenceAccession="NG_008805" sequenceVersion="2" change="g.154575_154585del">
            <Expression>NG_008805.2:g.154575_154585del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000138.5" sequenceAccession="NM_000138" sequenceVersion="5" change="c.2305_2315del" MANESelect="true">
            <Expression>NM_000138.5:c.2305_2315del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000129.3" sequenceAccession="NP_000129" sequenceVersion="3" change="p.Cys769fs">
            <Expression>NP_000129.3:p.Cys769fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_778" sequenceAccession="LRG_778">
            <Expression>LRG_778:g.154575_154585del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="1566911957" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000138.5(FBN1):c.2305_2315del (p.Cys769fs) AND multiple conditions" Accession="RCV000767972" Version="2">
        <ClassifiedConditionList TraitSetID="36141">
          <ClassifiedCondition DB="MedGen" ID="C0265287">Acromicric dysplasia</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C3541518">Ectopia lentis 1, isolated, autosomal dominant</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C3280054">Geleophysic dysplasia 2</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C1858556">MASS syndrome</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C0024796">Marfan syndrome</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C4310796">Progeroid and marfanoid aspect-lipodystrophy syndrome</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C1861456">Stiff skin syndrome</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C1869115">Weill-Marchesani syndrome 2, dominant</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-03-30" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2021-03-30" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2019-04-26" MostRecentSubmission="2023-05-20">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="36141" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="4217" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Stiff skin syndrome</ElementValue>
                <XRef ID="Stiff+skin+syndrome/6882" DB="Genetic Alliance" />
                <XRef ID="MONDO:0008492" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">SSKS</ElementValue>
                <XRef Type="MIM" ID="184900" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="5025" />
                <XRef ID="5025" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="2833" DB="Orphanet" />
              <XRef ID="C1861456" DB="MedGen" />
              <XRef ID="MONDO:0008492" DB="MONDO" />
              <XRef Type="MIM" ID="184900" DB="OMIM" />
            </Trait>
            <Trait ID="5118" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Glaucoma, Ectopia, Microspherophakia, Stiff joints and Short stature syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Weill-Marchesani syndrome 2, dominant</ElementValue>
                <XRef ID="MONDO:0012013" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Weill-Marchesani Syndrome, Autosomal Dominant</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Weill-Marchesani syndrome 2</ElementValue>
                <XRef ID="Weill-Marchesani+syndrome+2/9473" DB="Genetic Alliance" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">WMS2</ElementValue>
                <XRef Type="MIM" ID="608328" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">GEMSS</ElementValue>
                <XRef Type="MIM" ID="608328" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Weill-Marchesani syndrome (WMS) is a connective tissue disorder characterized by abnormalities of the lens of the eye, short stature, brachydactyly, joint stiffness, and cardiovascular defects. The ocular problems, typically recognized in childhood, include microspherophakia (small spherical lens), myopia secondary to the abnormal shape of the lens, ectopia lentis (abnormal position of the lens), and glaucoma, which can lead to blindness. Height of adult males is 142-169 cm; height of adult females is 130-157 cm. Autosomal recessive WMS cannot be distinguished from autosomal dominant WMS by clinical findings alone.</Attribute>
                <XRef ID="NBK1114" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">MESODERMAL DYSMORPHODYSTROPHY, CONGENITAL</Attribute>
                <XRef Type="MIM" ID="608328" DB="OMIM" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="2452" />
                <XRef ID="2452" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301293</ID>
                <ID Source="BookShelf">NBK1114</ID>
              </Citation>
              <XRef ID="2084" DB="Orphanet" />
              <XRef ID="C1869115" DB="MedGen" />
              <XRef ID="MONDO:0012013" DB="MONDO" />
              <XRef Type="MIM" ID="608328" DB="OMIM" />
            </Trait>
            <Trait ID="2825" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">MASS syndrome</ElementValue>
                <XRef ID="MASS+syndrome/4492" DB="Genetic Alliance" />
                <XRef ID="MONDO:0011431" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Overlap connective tissue disease</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">OCTD</ElementValue>
                <XRef Type="MIM" ID="604308" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="8489" />
                <XRef ID="8489" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="general" Abbrev="ACMG, 2012">
                <ID Source="PubMed">22237449</ID>
              </Citation>
              <XRef ID="99715" DB="Orphanet" />
              <XRef ID="C1858556" DB="MedGen" />
              <XRef ID="MONDO:0011431" DB="MONDO" />
              <XRef Type="MIM" ID="604308" DB="OMIM" />
            </Trait>
            <Trait ID="15880" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Acromicric dysplasia</ElementValue>
                <XRef ID="Acromicric+Dysplasia/167" DB="Genetic Alliance" />
                <XRef ID="MONDO:0007055" DB="MONDO" />
                <XRef ID="254090007" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Acromicric skeletal dysplasia</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">ACMICD</ElementValue>
                <XRef Type="MIM" ID="102370" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">GPHYSD1</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="7" />
                <XRef ID="7" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="969" DB="Orphanet" />
              <XRef ID="C0265287" DB="MedGen" />
              <XRef ID="MONDO:0007055" DB="MONDO" />
              <XRef Type="MIM" ID="102370" DB="OMIM" />
            </Trait>
            <Trait ID="35310" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Progeroid and marfanoid aspect-lipodystrophy syndrome</ElementValue>
                <XRef ID="MONDO:0014831" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">MARFANOID-PROGEROID-LIPODYSTROPHY SYNDROME</ElementValue>
                <XRef Type="MIM" ID="616914" DB="OMIM" />
                <XRef Type="Allelic variant" ID="134797.0070" DB="OMIM" />
                <XRef Type="Allelic variant" ID="134797.0066" DB="OMIM" />
                <XRef Type="Allelic variant" ID="134797.0069" DB="OMIM" />
                <XRef Type="Allelic variant" ID="134797.0064" DB="OMIM" />
                <XRef Type="Allelic variant" ID="134797.0065" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">MARFANOID-PROGEROID SYNDROME</ElementValue>
                <XRef Type="MIM" ID="616914" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">MARFAN-PROGEROID-LIPODYSTROPHY SYNDROME</ElementValue>
                <XRef Type="MIM" ID="616914" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Marfan lipodystrophy syndrome</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">MFLS</ElementValue>
                <XRef Type="MIM" ID="616914" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="17371" />
                <XRef ID="17371" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="300382" DB="Orphanet" />
              <XRef ID="C4310796" DB="MedGen" />
              <XRef ID="MONDO:0014831" DB="MONDO" />
              <XRef Type="MIM" ID="616914" DB="OMIM" />
            </Trait>
            <Trait ID="1137" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Ectopia lentis 1, isolated, autosomal dominant</ElementValue>
                <XRef ID="MONDO:0007514" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">ECTOL1</ElementValue>
                <XRef Type="MIM" ID="129600" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15062" />
                <XRef ID="15062" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="general" Abbrev="ACMG, 2012">
                <ID Source="PubMed">22237449</ID>
              </Citation>
              <XRef ID="1885" DB="Orphanet" />
              <XRef ID="C3541518" DB="MedGen" />
              <XRef ID="MONDO:0007514" DB="MONDO" />
              <XRef Type="MIM" ID="129600" DB="OMIM" />
            </Trait>
            <Trait ID="2645" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">MARFAN SYNDROME, TYPE I</ElementValue>
                <XRef Type="MIM" ID="154700" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Marfan syndrome, classic</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Marfan's syndrome</ElementValue>
                <XRef ID="Marfan+syndrome/4466" DB="Genetic Alliance" />
                <XRef ID="19346006" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Marfan syndrome</ElementValue>
                <XRef ID="MONDO:0007947" DB="MONDO" />
                <XRef ID="19346006" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Marfan syndrome type 1</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">MFS</ElementValue>
                <XRef Type="MIM" ID="154700" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">MFS1</ElementValue>
                <XRef Type="MIM" ID="154700" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6975" />
                <XRef ID="6975" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">FBN1-Related Marfan Syndrome</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">FBN1-related Marfan syndrome (Marfan syndrome), a systemic disorder of connective tissue with a high degree of clinical variability, comprises a broad phenotypic continuum ranging from mild (features of Marfan syndrome in one or a few systems) to severe and rapidly progressive neonatal multiorgan disease. Cardinal manifestations involve the ocular, skeletal, and cardiovascular systems. Ocular findings include myopia (&gt;50% of affected individuals); ectopia lentis (seen in approximately 60% of affected individuals); and an increased risk for retinal detachment, glaucoma, and early cataracts. Skeletal system manifestations include bone overgrowth and joint laxity; disproportionately long extremities for the size of the trunk (dolichostenomelia); overgrowth of the ribs that can push the sternum in (pectus excavatum) or out (pectus carinatum); and scoliosis that ranges from mild to severe and progressive. The major morbidity and early mortality in Marfan syndrome relate to the cardiovascular system and include dilatation of the aorta at the level of the sinuses of Valsalva (predisposing to aortic tear and rupture), mitral valve prolapse with or without regurgitation, tricuspid valve prolapse, and enlargement of the proximal pulmonary artery. Severe and prolonged regurgitation of the mitral and/or aortic valve can predispose to left ventricular dysfunction and occasionally heart failure. With proper management, the life expectancy of someone with Marfan syndrome approximates that of the general population.</Attribute>
                <XRef ID="NBK1335" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301510</ID>
                <ID Source="BookShelf">NBK1335</ID>
              </Citation>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGenetest, 2010">
                <ID Source="pmc">2987429</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2012">
                <ID Source="PubMed">22237449</ID>
              </Citation>
              <Citation Type="general" Abbrev="CSANZ, 2007">
                <ID Source="PubMed">17188935</ID>
              </Citation>
              <Citation Type="general" Abbrev="AHA, 2004">
                <ID Source="PubMed">15184297</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="Orphanet, 2007">
                <URL>https://www.orpha.net/data/patho/Pro/en/Emergency_Marfan.pdf</URL>
                <CitationText>Orphanet, Marfan Syndrome, 2007</CitationText>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2013">
                <ID Source="PubMed">23788249</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="Loeys et al., 2010">
                <ID Source="PubMed">20591885</ID>
              </Citation>
              <Citation Type="general" Abbrev="CCS, 2014">
                <ID Source="PubMed">24882528</ID>
              </Citation>
              <Citation Type="general" Abbrev="ESC, 2014">
                <ID Source="PubMed">25173340</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2015">
                <ID Source="PubMed">25356965</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2016">
                <ID Source="PubMed">27854360</ID>
                <ID Source="DOI">10.1038/gim.2016.190</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.0, 2021">
                <ID Source="PubMed">34012068</ID>
                <ID Source="DOI">10.1038/s41436-021-01172-3</ID>
              </Citation>
              <Citation Type="general" Abbrev="AAP, 2013">
                <ID Source="PubMed">24081994</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.1, 2022">
                <ID Source="PubMed">35802134</ID>
                <ID Source="DOI">10.1016/j.gim.2022.04.006</ID>
              </Citation>
              <Citation Type="general" Abbrev="CSANZ, 2017">
                <ID Source="PubMed">28161018</ID>
              </Citation>
              <XRef ID="284963" DB="Orphanet" />
              <XRef ID="558" DB="Orphanet" />
              <XRef ID="C0024796" DB="MedGen" />
              <XRef ID="MONDO:0007947" DB="MONDO" />
              <XRef Type="MIM" ID="154700" DB="OMIM" />
            </Trait>
            <Trait ID="16494" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Geleophysic dysplasia 2</ElementValue>
                <XRef ID="Geleophysic+dysplasia+2/8455" DB="Genetic Alliance" />
                <XRef ID="MONDO:0013612" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">GPHYSD2</ElementValue>
                <XRef Type="MIM" ID="614185" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15768" />
                <XRef ID="15768" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Geleophysic dysplasia, a progressive condition resembling a lysosomal storage disorder, is characterized by short stature, short hands and feet, progressive joint limitation and contractures, distinctive facial features, progressive cardiac valvular disease, and thickened skin. Intellect is normal. Major findings are likely to be present in the first year of life. Cardiac, respiratory, and lung involvement result in death before age five years in approximately 33% of individuals with ADAMTSL2-related geleophysic dysplasia.</Attribute>
                <XRef ID="NBK11168" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301776</ID>
                <ID Source="BookShelf">NBK11168</ID>
              </Citation>
              <XRef ID="2623" DB="Orphanet" />
              <XRef ID="C3280054" DB="MedGen" />
              <XRef ID="MONDO:0013612" DB="MONDO" />
              <XRef Type="MIM" ID="614185" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1762420" SubmissionDate="2023-05-02" DateLastUpdated="2023-05-20" DateCreated="2019-04-26">
        <ClinVarSubmissionID localKey="1915|OMIM:614185;608328;129600;604308;616914;102370;154700;184900" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV000898699" DateUpdated="2023-05-20" DateCreated="2019-04-26" Type="SCV" Version="2" SubmitterName="Center for Genomics, Ann and Robert H. Lurie Children's Hospital of Chicago" OrgID="506344" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-03-30">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>FBN1 NM_000138.4 exon 20 p.Cys769Glnfs*5 (c.2305_2315del): This variant has not been reported in the literature and is not present in large control databases. Evolutionary conservation and computational predictive tools for this variant are limited or unavailable. This variant is a deletion of 11 nucleotides and creates a premature stop codon 5 amino acids downstream from this location which results in an absent or abnormal protein. Loss of function variants are a known mechanism of disease for this gene (Dietz 2017 PMID: 20301510). Furthermore, this variant is predicted to affect a cysteine residue. Cysteine in the FBN1 gene is reported to have important functional relevance; variants that involve a cysteine residue are reported to be particularly significant (Dietz 2017 PMID: 20301510). In summary, this variant is classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FBN1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh38" Chr="15" alternateAllele="G" referenceAllele="GTTCAGTACACA" start="48496203" stop="48496214" variantLength="12" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="TraitChoice">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="614185" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="608328" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="129600" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="604308" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="616914" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="102370" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="154700" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="184900" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB4910108</SubmissionName>
          <SubmissionName>SUB13233500</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1762420" TraitType="Disease" MappingType="XRef" MappingValue="184900" MappingRef="OMIM">
        <MedGen CUI="C1861456" Name="Stiff skin syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1762420" TraitType="Disease" MappingType="XRef" MappingValue="616914" MappingRef="OMIM">
        <MedGen CUI="C4310796" Name="Progeroid and marfanoid aspect-lipodystrophy syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1762420" TraitType="Disease" MappingType="XRef" MappingValue="154700" MappingRef="OMIM">
        <MedGen CUI="C0024796" Name="Marfan syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1762420" TraitType="Disease" MappingType="XRef" MappingValue="604308" MappingRef="OMIM">
        <MedGen CUI="C1858556" Name="MASS syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1762420" TraitType="Disease" MappingType="XRef" MappingValue="608328" MappingRef="OMIM">
        <MedGen CUI="C1869115" Name="Weill-Marchesani syndrome 2, dominant" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1762420" TraitType="Disease" MappingType="XRef" MappingValue="614185" MappingRef="OMIM">
        <MedGen CUI="C3280054" Name="Geleophysic dysplasia 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1762420" TraitType="Disease" MappingType="XRef" MappingValue="129600" MappingRef="OMIM">
        <MedGen CUI="C3541518" Name="Ectopia lentis 1, isolated, autosomal dominant" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1762420" TraitType="Disease" MappingType="XRef" MappingValue="102370" MappingRef="OMIM">
        <MedGen CUI="C0265287" Name="Acromicric dysplasia" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

